Your browser doesn't support javascript.
loading
Engineered immunogen binding to alum adjuvant enhances humoral immunity.
Moyer, Tyson J; Kato, Yu; Abraham, Wuhbet; Chang, Jason Y H; Kulp, Daniel W; Watson, Nicki; Turner, Hannah L; Menis, Sergey; Abbott, Robert K; Bhiman, Jinal N; Melo, Mariane B; Simon, Hayley A; Herrera-De la Mata, Sara; Liang, Shu; Seumois, Gregory; Agarwal, Yash; Li, Na; Burton, Dennis R; Ward, Andrew B; Schief, William R; Crotty, Shane; Irvine, Darrell J.
Afiliación
  • Moyer TJ; Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA, USA.
  • Kato Y; Consortium for HIV/AIDS Vaccine Development, The Scripps Research Institute, La Jolla, CA, USA.
  • Abraham W; Consortium for HIV/AIDS Vaccine Development, The Scripps Research Institute, La Jolla, CA, USA.
  • Chang JYH; Division of Vaccine Discovery, La Jolla Institute for Immunology, La Jolla, CA, USA.
  • Kulp DW; Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA, USA.
  • Watson N; Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA, USA.
  • Turner HL; Consortium for HIV/AIDS Vaccine Development, The Scripps Research Institute, La Jolla, CA, USA.
  • Menis S; Vaccine and Immunotherapy Center, The Wistar Institute, Philadelphia, PA, USA.
  • Abbott RK; International AIDS Vaccine Initiative Neutralizing Antibody Center, The Scripps Research Institute, La Jolla, CA, USA.
  • Bhiman JN; Whitehead Institute of Biomedical Research, Cambridge, MA, USA.
  • Melo MB; Consortium for HIV/AIDS Vaccine Development, The Scripps Research Institute, La Jolla, CA, USA.
  • Simon HA; International AIDS Vaccine Initiative Neutralizing Antibody Center, The Scripps Research Institute, La Jolla, CA, USA.
  • Herrera-De la Mata S; Department of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, CA, USA.
  • Liang S; Consortium for HIV/AIDS Vaccine Development, The Scripps Research Institute, La Jolla, CA, USA.
  • Seumois G; International AIDS Vaccine Initiative Neutralizing Antibody Center, The Scripps Research Institute, La Jolla, CA, USA.
  • Agarwal Y; Consortium for HIV/AIDS Vaccine Development, The Scripps Research Institute, La Jolla, CA, USA.
  • Li N; Division of Vaccine Discovery, La Jolla Institute for Immunology, La Jolla, CA, USA.
  • Burton DR; Consortium for HIV/AIDS Vaccine Development, The Scripps Research Institute, La Jolla, CA, USA.
  • Ward AB; International AIDS Vaccine Initiative Neutralizing Antibody Center, The Scripps Research Institute, La Jolla, CA, USA.
  • Schief WR; Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA, USA.
  • Crotty S; Ragon Institute of Massachusetts General Hospital, Massachusetts Institute of Technology and Harvard University, Cambridge, MA, USA.
  • Irvine DJ; Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA, USA.
Nat Med ; 26(3): 430-440, 2020 03.
Article en En | MEDLINE | ID: mdl-32066977
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Péptidos / Ingeniería de Proteínas / Adyuvantes Inmunológicos / Hidróxido de Aluminio / Inmunidad Humoral Límite: Animals Idioma: En Revista: Nat Med Asunto de la revista: BIOLOGIA MOLECULAR / MEDICINA Año: 2020 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Péptidos / Ingeniería de Proteínas / Adyuvantes Inmunológicos / Hidróxido de Aluminio / Inmunidad Humoral Límite: Animals Idioma: En Revista: Nat Med Asunto de la revista: BIOLOGIA MOLECULAR / MEDICINA Año: 2020 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Estados Unidos